EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

dEREGulated pathways: unraveling the role of epiregulin in skin, kidney, and lung fibrosis

Aysan Ezaddoustdar, Daniel Kalina, Maximilian Bielohuby, Mario Boehm, Malgorzata Wygrecka iD

American Journal of Physiology-Cell Physiology · 2025

DOI: 10.1152/ajpcell.00813.2024 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift American Journal of Physiology-Cell Physiology, 2025. Verfasst von Aysan Ezaddoustdar und 4 weiteren Autor:innen. Beteiligte Einrichtung: Center for Infection and Genomics of the Lung, Faculty of Medicine, Justus Liebig University, Member of the German Center for Lung Research, Giessen,…. Hauptthemen laut MEDLINE: Epiregulin, Pulmonary Fibrosis, Kidney, Skin. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 101 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Bundesministerium für Bildung und Forschung (BMBF), Deutsche Forschungsgemeinschaft (DFG).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The epidermal growth factor receptor (EGFR) signaling pathway is an evolutionary conserved mechanism to control cell behavior during tissue development and homeostasis. Deregulation of this pathway has been associated with abnormal cell behavior, including hyperproliferation, senescence, and an inflammatory cell phenotype, thereby contributing to pathologies across a variety of organs, including the kidneys, skin, and lungs. To date, there are seven distinct EGFR ligands described. Although binding of these ligands to the receptor is cell type-specific and spatio-temporally controlled with distinct affinities and kinetics, epiregulin (EREG) stands out as a long-acting EGFR ligand that emerges under pathological conditions, particularly in tissue fibrosis. Although EREG has been extensively studied in cancer, its contribution to the maladaptive remodeling of tissue is elusive. The aim of this review is to highlight the role of EREG in skin, kidney, and lung fibrosis and to discuss opportunities for therapeutic intervention.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EpiregulinPulmonary FibrosisKidneySkinLungHumansAnimalsSignal TransductionErbB ReceptorsFibrosis

Stichwörter der Autor:innen

chronic inflammationepidermal growth factor receptorepiregulinfibrosis

Substanzen

EpiregulinErbB ReceptorsEREG protein, human

Autor:innen und Institutionen

  • Center for Infection and Genomics of the Lung, Faculty of Medicine, Justus Liebig University, Member of the German Center for Lung Research, Giessen, Germany.
  • CSL Innovation GmbH, Marburg, Germany.
  • Institute for Lung Health, Justus Liebig University, Giessen, Germany.

ORCID-Profile: Malgorzata Wygrecka

Förderung

  • Bundesministerium für Bildung und Forschung (BMBF)
  • Deutsche Forschungsgemeinschaft (DFG)

Zitieren

APA

Ezaddoustdar, A., Kalina, D., Bielohuby, M., Boehm, M., & Wygrecka, M. (2025). dEREGulated pathways: unraveling the role of epiregulin in skin, kidney, and lung fibrosis. American Journal of Physiology-Cell Physiology. https://doi.org/10.1152/ajpcell.00813.2024

Vancouver

Ezaddoustdar A, Kalina D, Bielohuby M, Boehm M, Wygrecka M. dEREGulated pathways: unraveling the role of epiregulin in skin, kidney, and lung fibrosis. American Journal of Physiology-Cell Physiology. 2025. doi:10.1152/ajpcell.00813.2024

BibTeX
@article{Ezaddoustdar2025,
  author = {Ezaddoustdar, Aysan and Kalina, Daniel and Bielohuby, Maximilian and Boehm, Mario and Wygrecka, Malgorzata},
  title = {dEREGulated pathways: unraveling the role of epiregulin in skin, kidney, and lung fibrosis},
  journal = {American Journal of Physiology-Cell Physiology},
  year = {2025},
  doi = {10.1152/ajpcell.00813.2024}
}
Kostenlos starten →